Concepedia

Daniela Gmehling

DG

6

Publications

349

Citations

6

H-Index

1995

Active since

Affiliations

University of Freiburg(Current)

Boehringer Ingelheim (Germany)

Bayer (Germany)

Daniela Gmehling is an author at University of Freiburg specializing in pharmacotherapy, medicine, and pharmacology.

Top concepts

Publications per year

1995–2009

6

Publications

6

Phase I Study of the Angiogenesis Inhibitor BIBF 1120 in Patients with Advanced Solid Tumors

K. Mross, Martin Štefanič, Daniela Gmehling et al. · Clinical Cancer Research · 2009 · 164 citations

Results from an in vitro and a clinical/pharmacological phase I study with the combination irinotecan and sorafenib

K. Mross, Simone Steinbild, F. Baas et al. · European Journal of Cancer · 2006 · 99 citations

, , +5

A clinical phase I, pharmacokinetic (PK), and pharmacodynamic study of twice daily BIBF 1120 in advanced cancer patients

K. Mross, Daniela Gmehling, Annette Frost et al. · Journal of Clinical Oncology · 2005 · 26 citations

, , +16

Lack of inducible nitric oxide synthase activity in T cell clones and T lymphocytes from naive and <i>Leishmania major</i>‐infected mice

H Thüring, Steffen Stenger, Daniela Gmehling et al. · European Journal of Immunology · 1995 · 24 citations

Treatment of Anthracycline Extravasation with Dexrazoxane – Clinical Experience

Annette Frost, Daniela Gmehling, Marc Azémar et al. · Oncology Research and Treatment · 2006 · 21 citations

Rows per page

1–5 of 6